You just read:

Zavante Therapeutics Presents Positive Results From NIH-Sponsored ZOLYD™ Phase 1 Trial At ASM Microbe 2017 Meeting

News provided by

Zavante Therapeutics, Inc.

Jun 05, 2017, 08:00 ET